Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gualou Danshen Granules for unstable angina pectoris
ChiCTR2000031780Phase 2Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gualou + danshen in unstable angina (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Seattle Angina Questionnaire score, Coronary Heart Disease Clinical Symptom Grading Scale and 1 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
gualou + danshen
03
Conditions
unstable angina
Beyond the preview
Go deeper on ChiCTR2000031780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031780.